Uncategorized

Why Eli Lilly (LLY) is Emerging as a Dividend Growth Leader in Pharma for 2025

Eli Lilly and Company (NYSE:LLY) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. In the past five years, the company has raised its payouts at an annual average rate of 16%. Its consistent track record makes it an appealing choice for investors focused on dividend growth, especially given the strength […]